Barclays PLC Karyopharm Therapeutics Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

A detailed history of Barclays PLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Barclays PLC holds 95,767 shares of KPTI stock, worth $74,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,767
Previous 95,767 -0.0%
Holding current value
$74,698
Previous $79,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
SELL
$0.7 - $1.06 $544,254 - $824,157
-777,507 Reduced 89.03%
95,767 $79,000
Q2 2024

Aug 14, 2024
SELL
$0.87 - $1.58 $17,000 - $30,874
-19,541 Reduced 2.19%
873,274 $758,000
Q1 2024

May 15, 2024
SELL
$0.72 - $1.66 $55,617 - $128,230
-77,247 Reduced 7.96%
892,815 $1.35 Million
Q4 2023

Feb 15, 2024
SELL
$0.68 - $1.31 $123,920 - $238,729
-182,236 Reduced 15.82%
970,062 $838,000
Q3 2023

Nov 07, 2023
BUY
$1.14 - $1.81 $52,368 - $83,145
45,937 Added 4.15%
1,152,298 $1.54 Million
Q2 2023

Aug 03, 2023
SELL
$1.79 - $4.59 $3.12 Million - $7.99 Million
-1,741,028 Reduced 61.14%
1,106,361 $1.98 Million
Q1 2023

May 04, 2023
BUY
$2.84 - $3.92 $5.11 Million - $7.06 Million
1,800,677 Added 172.03%
2,847,389 $11.1 Million
Q4 2022

Feb 13, 2023
BUY
$2.48 - $5.93 $1.47 Million - $3.51 Million
591,248 Added 129.81%
1,046,712 $3.56 Million
Q3 2022

Nov 03, 2022
BUY
$4.08 - $5.82 $1.52 Million - $2.17 Million
373,539 Added 455.95%
455,464 $2.49 Million
Q2 2022

Aug 12, 2022
SELL
$4.15 - $8.37 $24,065 - $48,537
-5,799 Reduced 6.61%
81,925 $369,000
Q1 2022

May 16, 2022
SELL
$5.91 - $14.38 $555,705 - $1.35 Million
-94,028 Reduced 51.73%
87,724 $646,000
Q4 2021

Feb 14, 2022
BUY
$5.21 - $8.61 $257,181 - $425,015
49,363 Added 37.29%
181,752 $1.17 Million
Q3 2021

Nov 09, 2021
SELL
$4.45 - $10.63 $295,417 - $705,683
-66,386 Reduced 33.4%
132,389 $770,000
Q2 2021

Aug 13, 2021
SELL
$8.11 - $11.11 $613,107 - $839,904
-75,599 Reduced 27.55%
198,775 $2.05 Million
Q1 2021

May 13, 2021
BUY
$9.85 - $17.69 $432,503 - $776,750
43,909 Added 19.05%
274,374 $2.89 Million
Q4 2020

Feb 11, 2021
BUY
$14.15 - $17.19 $2.5 Million - $3.04 Million
176,973 Added 330.84%
230,465 $3.57 Million
Q3 2020

Nov 12, 2020
SELL
$14.14 - $19.71 $261,915 - $365,088
-18,523 Reduced 25.72%
53,492 $781,000
Q2 2020

Aug 12, 2020
BUY
$16.6 - $25.25 $200,494 - $304,969
12,078 Added 20.15%
72,015 $1.36 Million
Q1 2020

May 13, 2020
SELL
$14.38 - $27.72 $394,155 - $759,805
-27,410 Reduced 31.38%
59,937 $1.15 Million
Q4 2019

Feb 10, 2020
BUY
$9.23 - $19.67 $484,990 - $1.03 Million
52,545 Added 150.98%
87,347 $1.67 Million
Q3 2019

Nov 14, 2019
SELL
$5.66 - $11.85 $58,586 - $122,659
-10,351 Reduced 22.92%
34,802 $335,000
Q2 2019

Aug 14, 2019
BUY
$4.32 - $6.43 $100,085 - $148,970
23,168 Added 105.38%
45,153 $270,000
Q1 2019

May 15, 2019
BUY
$4.12 - $10.25 $49,938 - $124,240
12,121 Added 122.88%
21,985 $128,000
Q4 2018

Feb 14, 2019
SELL
$8.2 - $16.95 $430,688 - $890,264
-52,523 Reduced 84.19%
9,864 $92,000
Q3 2018

Nov 14, 2018
BUY
$17.03 - $21.18 $601,874 - $748,543
35,342 Added 130.68%
62,387 $1.06 Million
Q2 2018

Aug 14, 2018
SELL
$12.0 - $19.88 $191,280 - $316,887
-15,940 Reduced 37.08%
27,045 $459,000
Q1 2018

May 15, 2018
BUY
$9.92 - $17.25 $143,433 - $249,417
14,459 Added 50.69%
42,985 $577,000
Q4 2017

Feb 14, 2018
BUY
$9.15 - $11.99 $195,526 - $256,214
21,369 Added 298.57%
28,526 $273,000
Q3 2017

Nov 14, 2017
BUY
$8.15 - $11.16 $58,329 - $79,872
7,157
7,157 $79,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $62.2M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email